Compare PFE & SCHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PFE | SCHW |
|---|---|---|
| Founded | 1849 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 145.4B | 163.3B |
| IPO Year | N/A | 1987 |
| Metric | PFE | SCHW |
|---|---|---|
| Price | $25.73 | $96.31 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 16 |
| Target Price | $28.30 | ★ $109.63 |
| AVG Volume (30 Days) | ★ 57.7M | 8.8M |
| Earning Date | 11-04-2025 | 01-20-2026 |
| Dividend Yield | ★ 6.67% | 1.13% |
| EPS Growth | ★ 131.89 | 66.73 |
| EPS | 1.73 | ★ 4.27 |
| Revenue | ★ $62,785,000,000.00 | $22,914,000,000.00 |
| Revenue This Year | N/A | $23.93 |
| Revenue Next Year | N/A | $9.98 |
| P/E Ratio | ★ $14.93 | $22.45 |
| Revenue Growth | 3.89 | ★ 21.67 |
| 52 Week Low | $20.92 | $65.88 |
| 52 Week High | $27.69 | $99.59 |
| Indicator | PFE | SCHW |
|---|---|---|
| Relative Strength Index (RSI) | 55.45 | 59.99 |
| Support Level | $25.13 | $92.75 |
| Resistance Level | $26.19 | $95.62 |
| Average True Range (ATR) | 0.54 | 1.82 |
| MACD | 0.02 | 0.40 |
| Stochastic Oscillator | 77.75 | 91.04 |
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
Charles Schwab is one of the largest retail-oriented financial-services companies in the US, with $11.6 trillion in client assets across its brokerage, banking, asset management, custody, financial advisory, and wealth-management businesses at the end of the third quarter. While best known for its retail brokerage offering, Schwab generates the lion's share of its revenue and profits through its Charles Schwab Bank and asset management segments. The firm is a dominant player in registered investment advisor custody, with over 40% market share, and has recently pushed into wealth management with robo-advisory, direct indexing, and other managed-investment solutions.